SCP
EW icon

Sivia Capital Partners’s Edwards Lifesciences EW Stock Holding History

Sivia Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,984
Closed -$239K – 567
2026
Q1 		$239K Sell
2,984
-688
-19% -$56.7K 0.05% 396
2025
Q4 		$313K Buy
3,672
+566
+18% +$46.5K 0.06% 394
2025
Q3 		$242K Buy
+3,106
New +$243K 0.07% 395

Other funds holding EW

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Sivia Capital Partners's EW Position: Q2 2026 in Review

Sivia Capital Partners sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 2,984 shares — an estimated $239K sold.

Sivia Capital Partners first reported a position in EW in Q3 2025 and held it in 3 quarters. The position peaked at $313K in Q4 2025. 720 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sivia Capital Partners reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Sivia Capital Partners sold 2,984 Edwards Lifesciences shares in Q2 2026, an estimated $239K.
  • Sivia Capital Partners first reported a position in Edwards Lifesciences in Q3 2025 and held it in 3 quarters.
  • Sivia Capital Partners's Edwards Lifesciences position peaked at $313K in Q4 2025.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.